Phase 1 Pancreatic Cancers Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers

Amgen350 enrolled77 locationsNCT06360354

Recruiting

Phase 1

A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer

Advanced Pancreatic Cancers

Tianjin Medical University Cancer Institute and Hospital21 enrolled1 locationNCT06760364